YoungYun
YoungYun
暂无个人介绍
IP属地:未知
6关注
19粉丝
0主题
0勋章
avatarYoungYun
2021-12-24
As the busy holiday shopping season starts to come to an end, Apple is making it as easy as possible for last-minute shoppers to get their hands on the latest gear. The company is now offering free two-hour delivery in major metro areas for iPhone, iPad, Mac, and Apple Watch orders. Lets just see if EOY ER reflects this news and beats big with good guidance .. not the Supply chain problem like a lot are stating in their reports and conference calls ..$Apple(AAPL)$
avatarYoungYun
2021-12-22
Cathie Wood continues buying XPEV. Don't be surprised or believe the shorts. Long term winners are easy to spot for intelligent investors. ridiculously low volume in XPEV and it was still over a 7% pullback. Wall Street was busy adding shares and taking away stocks from weaker hands. Retail is watching CNBC and getting scared over nothing. If you play fantasy football, you already know NFL players were getting covid before today...every single week. Nothing had changed. Just more fear of the same boogie monster we know how to deal with....get vaccinated and wear masks. Those that don't allow viruses like this to spread more easily and mutate and get worse. Companies are doing great compared to the pandemic shutdown. We are never locking down again without a war or a zombies. I expect to be
avatarYoungYun
2021-12-17
Spotlight Asset Group Inc. Purchases Shares of 535 Moderna. Spotlight Asset Group Inc. acquired a new stake in shares of Moderna, Inc. in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 535 shares of the company’s stock, valued at approximately $206,000. We should follow the institution investors because their volumes are larger. $Moderna, Inc.(MRNA)$
avatarYoungYun
2021-12-16
Do you have an imagination? For just a moment imagine that the politics of Disney was completely unknown. The average customer, guest, or shareholder knew virtually nothing about the politics of management. What would the share price be? I would estimate about $250, with a 3% dividend.$Walt Disney(DIS)$
avatarYoungYun
2021-12-16
On the last day of trading AMD closed at $91.71. And on 15 January 2021 AMD closed at $88.21. The 2020 Santa Rally brought us a nearly 10% drop! So, history tells us that amd will continue downwards possibly to January 15? BUT WAIT, Lisa Su emphatically states that the xlnx deal will be by eoy. The early January conference guarantees nothing, actual numbers with earnings in 41 days will tell us 2022 direction of amd. IMO......$AMD(AMD)$ $Xilinx(XLNX)$
avatarYoungYun
2021-12-10
U.S. consumer spending on video-game products from July through September rose 7% to $13.3 billion, according to the NPD Group, a market research firm. The PlayStation 5 and Xbox Series consoles helped drive that demand, as did subscriptions and mobile gaming, according to NPD. However, the firm said that the market experienced "a slight decline" in gamers overall. The chip shortage has disrupted product releases and availability for gaming consoles. Does this mean that gme's gaming business has been weak? $GameStop(GME)$
avatarYoungYun
2021-12-10
I added a few shares pre-market @20.02. What is making FUBO jump is the prospect of TV-online sports betting, after DIS conf. call when they mentioned they had looked into it for ESPN. Like I said, if FUBO can get a part of that it's a moonshot... I'll get a few more, <20 is low cost shares. If there's a further story of FUBO TV betting, the price jump and ensuing short squeeze will drive it way up...$fuboTV Inc.(FUBO)$
avatarYoungYun
2021-12-09
Really question the findings by PFE & BNTX. Their study is based on pseudovirus. The Sigal Lab & Ciesek team used live virus, and both had shown much sharper declines than in the makers' study. The only bright spot is 2xModerna + Pfizer booster that showed respectable titer vs. Omicron in Ciesek's study. No results on Moderna booster yet. The mkt doesn't believe what Bourla, Sahin said either, judging by the BNTX performance.$Moderna, Inc.(MRNA)$ $Pfizer(PFE)$ $BioNTech SE(BNTX)$
avatarYoungYun
2021-12-09
For one interest rates're not gonna soar lol. There will be a few rate hikes next year of 25 basis points, nothing. And yes it will hurt SE in the short term but most of that is probably already priced in.This is an international company, US interest rates won’t have the same impact in the business as US companies. I'm 5 years won't matter because this will be $1,000.$Sea Ltd(SE)$
avatarYoungYun
2021-12-08
Nobody wants to grab GRAB. Fine with me. Only a matter of time before we're running with the bulls. I'll just accumulate$Grab Holdings(GRAB)$
avatarYoungYun
2021-12-08
Quick...sell your short interest NOW !!! Just takes 1 BTC whale and the squeeze is on. The xmas rally has started and the FUD aint working. Dont be the last one out Over 20 percent upsize coming MARA Adding thousands of miners every month 5 plus EH and climbing Good SEC news could happen any day now. Too risky to hold short bail out while you can still buy coffee$Marathon Digital Holdings Inc(MARA)$
avatarYoungYun
2021-12-07
I tend to follow the action on Binance as they are the crypto giant with BTC spot trading of $28B/day compared to #2 Coinbase at about $6B/day. Binance Derivatives market is huge at roughly $73B/day with the next largest (OKEx) at $19B. Over the past 24 hours to Sunday afternoon, a shift from inflows to outflows has occurred at Binance and other sites. If this trend continues, we should see a bounce back in price sometime overnight. The 'buy the dip' mentality is in play but we still need more institutional buyers to show up. Without a Spot ETF approved by the SEC, institutions have been slow to respond. Transactions are continuing the slow rise and available supply is starting to drop again, now at 2.298M, so these trends will help the rise in BTC price. Sudden BTC drops are tough to take
avatarYoungYun
2021-12-07
All depends on btc. I can tell you if riot is at 30 with btc at 50k if btc goes back to 60k it will get there and past it. Last time riot was at 46 btc was at 65k…$Riot Blockchain, Inc.(RIOT)$
avatarYoungYun
2021-12-06
investors are better off looking beyond the biggest AI names to stay clear of regulatory risk. Many smaller names are private, or spoken for, like Xilinx, which is being bought by Advanced Micro Devices (AMD). One chip up-and-comer is Marvell Technology (MRVL), valued at $69 billion. Bank of America recently called it the next $100 billion cloud leader.$Xilinx(XLNX)$ $Marvell Technology(MRVL)$ $AMD(AMD)$
avatarYoungYun
2021-12-06
SoFi institutional ownership has just increased to record yearly high, smart money is loading the boat quietly.$SoFi Technologies Inc.(SOFI)$
avatarYoungYun
2021-12-03
I don’t think we will know fair value until we see Quest 2 sales and the growth in the Reality Labs portion of the business. So I guess I will hold strong and count on the legacy ads business to continue to produce strong results. Long term as online advertising worldwide grows this is a no brainer. Short term we may have to wait this volatility cycle out when the market snaps back to normal. It may trade neutral until the Fed meeting. $Meta Platforms, Inc.(FB)$
avatarYoungYun
2021-12-03
Pfizer has been profitable last few monthsNow I am planning to 100x by buying NRXP BIOTECHMAKER of only worlds ARDS DRUG ZYESAMIAND BRILIFE COVID VACCINE$Pfizer(PFE)$
avatarYoungYun
2021-12-03
What news? Unidentified sources familiar with the situation said DWAC/TMTG are seeking 1B in pipe funding. Before this we had heard they were "seeking" 500mil. So the new "news" is that they are seeking (thus needing) more capital to get this thing off the grand. When was the last official press release from either DWAC or TMTG management?$Digital World Acquisition Corp(DWAC)$
avatarYoungYun
2021-12-02
Current monoclonal antibody treatment may not be as effective against Omicron, according to Regeneron. This, if accurate, makes Paxlovid, really, the only game in town in hospital settings as a first line treatment. Regeneron was tracking for roughly $10 billion in annualized revenues for 2022. They are BOTH great investments. Both have an awesome array of patented drugs and pipelines. REGN has a bulletproof balance sheet, remarkably small share count (which keeps getting smaller) and a lovely, low P/E. It also still has very high demand for its monoclonals which treat and prevent the ongoing dominant Delta strain. Plus, Regeneron been preparing for variants over the past year and will undoubtedly have a new set of effective antibodies if needed. It will always be part of the "game in town
avatarYoungYun
2021-12-02
Reutrs: [Moderna could be sued over vaccines as court upholds Arbutus patents] but read further down the article: [Jefferies analyst Dennis Ding said an infringement lawsuit was possible, but could drag for years, adding that Arbutus will likely settle for a small royalty. "When you're thinking about the revenue opportunity from the vaccine, so just like $10 (billion) to $20 billion annually, a small low-single-digit royalty is immaterial to Moderna," he said.] Moderna's earlier candidates with some exceptions, such as the AZD8601 with Astrazeneca, are more susceptible to the ruling. If anything, the mRNA-1273 is one of the least likely to be affected by the patent because Moderna uses a modified version of the platform by opting to use an IONIZABLE LIPID "SM-102" instead of the CATIONIC

去老虎APP查看更多动态